1 / 11

Business Presentation June 2009

Business Presentation June 2009. prepared for. Myocet Forecast. MBC Total Market (IMS data u nits ). Total Market 2005 (IMS data). Myocet Forecast. 5 years forecast. Abelcet Forecast. Analysis of the environment.

lixue
Download Presentation

Business Presentation June 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Business Presentation June 2009

  2. prepared for

  3. MyocetForecast

  4. MBCTotal Market (IMS data units)

  5. Total Market2005 (IMS data)

  6. MyocetForecast 5 years forecast

  7. Abelcet Forecast

  8. Analysis of theenvironment • Erkim is the exclusive distributor of Gilead. Gilead set up its Turkish operation and trying to get the marketing rights back from Erkim. They already got back the rights for Hepsera paying a compansation fee to Erkim. The situation is unclear for Ambisome. Gilead was expecting the rights to be transfered in 2010 but the rumor is Erkim will manage not to give the rights until 2013. From time to time because of lack of cooperation and probably other reasons Gilead does not supply necessary amount of Ambisome to Erkim. • IMS does not reflect the real sales as tenders are taking place for this product. Tenders are for hospital products. • It is a very good time to relaunch Abelcet as Erkim is not promoting Ambisome and having problems with Gilead. Additionally there are rumors for Erkim going to bankruptcy. • Doctors are not happy with the way Erkim treats them.

  9. Scenario 1 (current SUT) Total Market (for 5 coming years)

  10. Scenario 2 (hypotheticalnew SUT) Total Market Units (for 5 coming years)

More Related